Vir Biotechnology (VIR) Net Equity Issued and Repurchased (2018 - 2026)
Vir Biotechnology (VIR) posted Net Equity Issued and Repurchased of -$160.74 million for Q2 2026, compared with $1.16 million a year earlier.
Powered by 
Analysis
Vir Biotechnology (VIR) Net Equity Issued and Repurchased (2018 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Net Equity Issued and Repurchased at Vir Biotechnology was $2.65 million, down 9.0% year-over-year; for FY2025, it came in at $2.8 million, down 25.7% from FY2024.
- Annual Net Equity Issued and Repurchased has declined for five consecutive years, with a five-year compound annual growth rate of -61.3% (FY2020 to FY2025).
- In prior years, Vir Biotechnology's Net Equity Issued and Repurchased was $3.76 million in FY2024 (-12.1%), $4.28 million in FY2023 (-5.5%), $4.53 million in FY2022 (-65.3%) and $13.08 million in FY2021 (-96.0%).
- The Q2 2026 figure stands as the lowest quarterly Net Equity Issued and Repurchased in data going back to Q4 2018.
- On a year-over-year basis, Net Equity Issued and Repurchased increased in two of the last four quarters, with growth averaging 34.9%.
- The strongest year-over-year quarter for Net Equity Issued and Repurchased in the past five years was Q1 2023, with growth of 377.3%; the weakest was Q3 2021, with a decline of 98.8%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 43.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 6.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 9.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 47.70 Mn |
| 10 | Vir Biotechnology | 1.89 Bn | 1.89 Bn | 238.95 Mn | -160.74 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -160.74 Mn |
| Mar 31, 2026 | 162.35 Mn |
| Dec 31, 2025 | 1.04 Mn |
| Jun 30, 2025 | 1.16 Mn |
| Mar 31, 2025 | 598,000.00 |
| Dec 31, 2024 | 1.16 Mn |
| Jun 30, 2024 | 2.38 Mn |
| Mar 31, 2024 | 221,000.00 |
| Dec 31, 2023 | 888,000.00 |
| Sep 30, 2023 | 343,000.00 |
| Jun 30, 2023 | 742,000.00 |
| Mar 31, 2023 | 2.31 Mn |
| Dec 31, 2022 | 932,000.00 |
| Sep 30, 2022 | 1.54 Mn |
| Jun 30, 2022 | 1.58 Mn |
| Mar 31, 2022 | 484,000.00 |
| Dec 31, 2021 | 3.44 Mn |
| Sep 30, 2021 | 3.69 Mn |
| Jun 30, 2021 | 3.59 Mn |
| Mar 31, 2021 | 2.35 Mn |
API Access
Vir Biotechnology Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=VIR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "VIR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=VIR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();